|Bid||0.905 x 2100|
|Ask||0.908 x 400|
|Day's range||0.901 - 0.930|
|52-week range||0.720 - 3.200|
|PE ratio (TTM)||N/A|
|Earnings date||14 Aug 2017 - 18 Aug 2017|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.50|
The multi-year, comprehensive laboratory deal to help LabCorp (LH) provide high-quality, high-value and standardized laboratory diagnostics for Appalachian Regional Healthcare.
PARSIPPANY, N.J. , Jan. 25, 2018 (GLOBE NEWSWIRE) -- INTERPACE DIAGNOSTICS GROUP, INC.(NASDAQ:IDXG), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services for improved patient diagnosis and management, today announced that its President & CEO, Jack Stover will present at NobleCon14 - Noble Capital Markets’ Fourteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida - on Monday, January 29, 2018 at 5:00 pm ET. ...